ID26700A - Senyawa-senyawa azapolisiklik yang bercampur dengan aril - Google Patents

Senyawa-senyawa azapolisiklik yang bercampur dengan aril

Info

Publication number
ID26700A
ID26700A IDW20002185A ID20002185A ID26700A ID 26700 A ID26700 A ID 26700A ID W20002185 A IDW20002185 A ID W20002185A ID 20002185 A ID20002185 A ID 20002185A ID 26700 A ID26700 A ID 26700A
Authority
ID
Indonesia
Prior art keywords
azapoliciclic
aril
arrived
compounds
compounds arrived
Prior art date
Application number
IDW20002185A
Other languages
English (en)
Indonesian (id)
Inventor
Jotham Wadsworth Coe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ID26700A publication Critical patent/ID26700A/id

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22—Bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IDW20002185A 1998-04-29 1999-04-08 Senyawa-senyawa azapolisiklik yang bercampur dengan aril ID26700A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8355698P 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
ID26700A true ID26700A (id) 2001-02-01

Family

ID=22179102

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20002185A ID26700A (id) 1998-04-29 1999-04-08 Senyawa-senyawa azapolisiklik yang bercampur dengan aril

Country Status (42)

Country Link
US (3) US6462035B1 (fr)
EP (1) EP1076650B1 (fr)
JP (1) JP2002513007A (fr)
KR (1) KR100420423B1 (fr)
CN (1) CN1144787C (fr)
AP (1) AP1154A (fr)
AR (1) AR018596A1 (fr)
AT (1) ATE258921T1 (fr)
AU (1) AU749831B2 (fr)
BG (1) BG64556B1 (fr)
BR (1) BR9910058A (fr)
CA (1) CA2330576A1 (fr)
CO (1) CO5021124A1 (fr)
DE (1) DE69914594T2 (fr)
DK (1) DK1076650T3 (fr)
DZ (1) DZ2778A1 (fr)
EA (1) EA003669B1 (fr)
ES (1) ES2213354T3 (fr)
GT (1) GT199900059A (fr)
HK (1) HK1036453A1 (fr)
HR (1) HRP20000731A2 (fr)
HU (1) HUP0103340A3 (fr)
ID (1) ID26700A (fr)
IL (1) IL138917A0 (fr)
IS (1) IS5649A (fr)
MA (1) MA26623A1 (fr)
MY (1) MY133474A (fr)
NO (1) NO317300B1 (fr)
NZ (1) NZ507035A (fr)
OA (1) OA11506A (fr)
PA (1) PA8471301A1 (fr)
PE (1) PE20000435A1 (fr)
PL (1) PL344010A1 (fr)
PT (1) PT1076650E (fr)
SK (1) SK15952000A3 (fr)
TN (1) TNSN99080A1 (fr)
TR (1) TR200003122T2 (fr)
UA (1) UA61991C2 (fr)
UY (1) UY25636A1 (fr)
WO (1) WO1999055680A1 (fr)
YU (1) YU64400A (fr)
ZA (1) ZA992971B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1044189T4 (en) 1997-12-31 2015-03-30 Pfizer Prod Inc Aryl-fused fused azapolycyclic connections
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
MXPA03009527A (es) * 2001-04-20 2004-02-12 Pfizer Prod Inc PROCEDIMIENTO PARA LA PREPARACIoN DE INDENOS 1,3-SUSTITUIDOS Y COMPUESTOS AZAPOLICICLICOS CONDENSADOS CON ARILO.
JP2005507411A (ja) * 2001-10-31 2005-03-17 ファイザー・プロダクツ・インク 下肢静止不能症候群の治療における、ニコチン性アセチルコリン受容体アゴニスト。
EP1451202B1 (fr) 2001-11-30 2008-08-20 Pfizer Products Inc. Composes azapolycycliques a fusion aryle
WO2003093258A2 (fr) * 2002-05-03 2003-11-13 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Nouveaux derives de spirocetone et d'acide carboxylique utilises comme inhibiteurs specifiques de (po3h2)ser/(po3h2)thr-pro-specifique peptidyl-prolyl-cis/trans-isomerases
US20040224963A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20040224962A1 (en) * 2003-05-09 2004-11-11 Pfizer Inc Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
WO2005007630A2 (fr) * 2003-07-21 2005-01-27 Pfizer Products Inc. Composes azapolycycliques fusionnes avec aryle
CA2529193A1 (fr) 2003-07-21 2005-01-27 Pfizer Products Inc. Composes azapolycycliques fusionnes avec heteroaryle pour reduire la dependance a la nicotine
US20050043407A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
WO2006061711A1 (fr) * 2004-12-07 2006-06-15 Pfizer Products Inc. Derives de 1,2,3,3a,8,8a-hexahydro-2,7a-diaza-cyclopenta[a]inden-7-one se liant a des sites de recepteurs nicotiniques neuronaux specifiques de l'acetylcholine, utiles dans la modulation de la fonction cholinergique et dans le traitement de troubles de dependance
US20060210497A1 (en) * 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives
US20060210498A1 (en) 2005-03-18 2006-09-21 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Novel resorcinol derivatives for skin
DE102005061426A1 (de) * 2005-12-22 2007-07-05 Grünenthal GmbH Substituierte tricyclische Piperidon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3687937A (en) * 1970-06-23 1972-08-29 Us Of America The 1,5-methano-3-benzazocine derivatives
JPS4914473A (fr) * 1972-06-09 1974-02-07
JPS4924968A (fr) * 1972-07-01 1974-03-05

Also Published As

Publication number Publication date
US20030008890A1 (en) 2003-01-09
US6462035B1 (en) 2002-10-08
HRP20000731A2 (en) 2001-06-30
NO20005397L (no) 2000-10-26
TR200003122T2 (tr) 2001-03-21
HUP0103340A2 (hu) 2002-02-28
SK15952000A3 (sk) 2002-06-04
KR20010043143A (ko) 2001-05-25
DZ2778A1 (fr) 2005-04-23
UA61991C2 (en) 2003-12-15
US6706702B2 (en) 2004-03-16
KR100420423B1 (ko) 2004-03-04
AP9901524A0 (en) 1999-06-30
CN1298394A (zh) 2001-06-06
US20040167149A1 (en) 2004-08-26
ES2213354T3 (es) 2004-08-16
HK1036453A1 (en) 2002-01-04
YU64400A (sh) 2003-01-31
BG104983A (en) 2001-09-28
AR018596A1 (es) 2001-11-28
NZ507035A (en) 2003-05-30
HUP0103340A3 (en) 2002-10-28
CN1144787C (zh) 2004-04-07
IS5649A (is) 2000-09-29
AP1154A (en) 2003-03-27
US7122534B2 (en) 2006-10-17
ATE258921T1 (de) 2004-02-15
UY25636A1 (es) 2000-02-23
NO317300B1 (no) 2004-10-04
PE20000435A1 (es) 2000-05-26
CO5021124A1 (es) 2001-03-27
CA2330576A1 (fr) 1999-11-04
EA200000996A1 (ru) 2001-06-25
DK1076650T3 (da) 2004-05-24
TNSN99080A1 (fr) 2005-11-10
JP2002513007A (ja) 2002-05-08
IL138917A0 (en) 2001-11-25
EA003669B1 (ru) 2003-08-28
BG64556B1 (bg) 2005-07-29
PT1076650E (pt) 2004-05-31
EP1076650A1 (fr) 2001-02-21
MA26623A1 (fr) 2004-12-20
AU2951699A (en) 1999-11-16
ZA992971B (en) 2000-10-30
EP1076650B1 (fr) 2004-02-04
DE69914594T2 (de) 2004-12-09
AU749831B2 (en) 2002-07-04
WO1999055680A1 (fr) 1999-11-04
OA11506A (en) 2004-05-14
PA8471301A1 (es) 2000-09-29
PL344010A1 (en) 2001-09-24
BR9910058A (pt) 2000-12-26
NO20005397D0 (no) 2000-10-26
GT199900059A (es) 2000-10-11
DE69914594D1 (de) 2004-03-11
MY133474A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
DE69937339D1 (de) Bakterizide
LTC1124961I2 (lt) Trombopoetino junginiai
ATE229954T1 (de) Betacarbolinverbindungen
ID28266A (id) Senyawa-senyawa amidin
NO992430D0 (no) R°rkobling
NO20011745L (no) Forbindelser
FI4209U1 (fi) Uusia yhdisteitä
ID23287A (id) Trisiklik tersubstitusi
NO992198D0 (no) R°rledningspigg
ID26700A (id) Senyawa-senyawa azapolisiklik yang bercampur dengan aril
ID27004A (id) Senyawa-senyawa kalsilitik
NO20006662D0 (no) Fluorfenylresin-forbindelser
DE69937136D1 (de) Lackiervorrichtung
DE29811362U1 (de) Repellent
DE59912188D1 (de) Substituierte phenyluracile
ATE303996T1 (de) Substituierte acylaminophenyl-uracile
DE59911610D1 (de) Substituierte benzoylcyclohexandione
DE29902512U1 (de) Schraubendreher
DE29810876U1 (de) Schraubendreher
DE29820168U1 (de) Schraubwerkzeug
DE69905321T2 (de) Pflugschar
FR2787432B1 (fr) Decapsuleur
NO995599D0 (no) Rengjöringsanordning
NO983018D0 (no) R°ranordning
NO984675D0 (no) Gass-gravitasjonsteori